Cita APA (7th ed.)
Haque, A. A. (2026). AN IN-SILICO APPROACH TO REPURPOSE FDA-APPROVED PROPRANOLOL AGAINST PD-L1 PROTEIN TARGET IN CANCER TREATMENT. BME DEPT. MIST.
Cita Chicago (17th ed.)
Haque, AKM Arefen. AN IN-SILICO APPROACH TO REPURPOSE FDA-APPROVED PROPRANOLOL AGAINST PD-L1 PROTEIN TARGET IN CANCER TREATMENT. Dhaka: BME DEPT. MIST, 2026.
Cita MLA (9th ed.)
Haque, AKM Arefen. AN IN-SILICO APPROACH TO REPURPOSE FDA-APPROVED PROPRANOLOL AGAINST PD-L1 PROTEIN TARGET IN CANCER TREATMENT. BME DEPT. MIST, 2026.
Atenció: Aquestes cites poden no estar 100% correctes.